Insiders · VXRT

David E. Wheadon

Director at Vaxart, Inc. (VXRT) since April 2021

David E. Wheadon has filed 24 insider reports with the SEC since April 2021, as director at Vaxart, Inc. (VXRT), director at Sotera Health Co (SHC) and director at Indivior Pharmaceuticals, Inc. (INDV) and at 2 more companies. In the last 12 months David E. Wheadon bought $62.7K of stock on the open market. The latest filing, on July 18, 2026, reports grant or award at Vaxart, Inc. (VXRT).

Filings
24
Companies
5
Bought on market
$62.7K
Sold on market
None

Companies where David E. Wheadon is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Vaxart, Inc. logo
VXRT
Vaxart, Inc.
Directorsince April 202186,150Jul 18, 2026
Sotera Health Co logo
SHC
Sotera Health Co
Directorsince May 202189,882$15.91May 27, 2026
Indivior Pharmaceuticals, Inc. logo
INDV
Indivior Pharmaceuticals, Inc.
Directorsince January 202630,780$62.7K$35.39$36.28+2.5%May 14, 2026
Karuna Therapeutics, Inc. logo
KRTX
Karuna Therapeutics, Inc.
Director0Mar 18, 2024
ChemoCentryx, Inc. logo
CCXI
ChemoCentryx, Inc.
Directorsince May 2022$11.26Oct 24, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare David E. Wheadon with

Other insiders at the same companies

Questions about David E. Wheadon

What is David E. Wheadon's role at Vaxart, Inc.?
David E. Wheadon reports to the SEC as director at Vaxart, Inc. (VXRT), according to the latest filing on July 18, 2026. David E. Wheadon has also filed as director at Sotera Health Co (SHC), director at Indivior Pharmaceuticals, Inc. (INDV), director at Karuna Therapeutics, Inc. (KRTX) and director at ChemoCentryx, Inc. (CCXI).
How many shares does David E. Wheadon own?
After the latest filing that states it, David E. Wheadon directly owned 86,150 shares of Vaxart, Inc. (VXRT), 89,882 shares of Sotera Health Co (SHC) and 30,780 shares of Indivior Pharmaceuticals, Inc. (INDV). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David E. Wheadon bought or sold stock recently?
The most recent open-market purchase was on January 5, 2026: bought 1,771 shares of Indivior PLC (INDV) for $62.7K at an average of $35.39.
How do I get alerts when David E. Wheadon files?
Follow David E. Wheadon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David E. Wheadon (SEC CIK 0001789507). Totals count each trade once, skipping amendments whose original is on file, from Apr 23, 2021 on. View on SEC EDGAR · Get this as JSON